MedPath

Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants

Completed
Conditions
Pneumothorax and Air Leak
Atelectasis Neonatal
Interventions
Other: Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT)
Registration Number
NCT04848727
Lead Sponsor
Sharp HealthCare
Brief Summary

To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography

Detailed Description

To quantify the changes in regional lung air content associated with the variations of the respiratory support settings, the following approach will be used. The changes in local air content will be determined in the selected EIT region of interest (ROI) in terms of a change in local average lung density and relative impedance change with respect to a reference air content.

* TimePeriod 1 (t1): The reference lung air content will be measured once the asymmetric lung disease is identified on chest x-ray.

* TimePeriod 2 (t2): A post-lung disease EIT measurement will be obtained at 6-24 hours later or immediately after therapy (i.e. chest tube placement or needle decompression).

Eligible infants with confirmed asymmetric lung disease (atelectasis or pneumothorax) by radiographic images requiring no respiratory support or on mechanical support or nCPAP therapy of 5-8 cm H20 achieved with a ventilator, an underwater "bubble" system, or a variable-flow device will be enrolled. All of these methods of providing the therapy are done with FDA approved devices currently used in the NICU.

EIT data will be acquired using The LuMon Monitor-Neo, GUI software 1.0.x.x/TIC software 1.6.x.xxx (SenTec, Landquart, Switzerland). The EIT system will be placed at the subject's bedside to collect EIT measurements: Ventilation distribution%, changes in regional aeration in arbitrary units (AU), dependent and non-dependent silent spaces.

A data acquisition cart will also be placed at the subject's bedside to collect hemodynamic and respiratory parameters measurements including: Heart rate (HR), blood pressure (BP), respiratory rate (RR), fraction of inspired oxygen (FiO2), transcutaneous carbon dioxide (TcCO2), and peripheral oxygen saturation (SpO2) via bedside monitoring devices.

The LuMon belts for neonates are disposable single-patient use belts that are adhesive-free and consists of 32 electrodes which are sized to the infant's chest circumference, generally at the 4th - 6th rib. Warmed NeoContactAgent (ingredients: Aqua, Glycerol, Sodium chloride) will be applied to the belt before placing on the infant. The embedded position sensor permits the LuMon System to measure and display the patient's position. The soft and expandable closure band prevents the chest from being constrained by the belt and, consequently, prevents restrictions to breathing and increased work of breathing.

EIT measurements and data will be collected on each timeperiods (t1 and t2) for approximately 15-30 minutes on invasive or non-invasive ventilatory support.

The EIT measurements may be repeated on an eligible participant if a reoccurrence of a confirmed asymmetric lung disease, atelectasis or pneumothorax, is identified on a radiographic image.

EIT is currently not used for patient care management at SMBHWN. EIT's use for patient care management is purely experimental. EIT, when used solely for physiologic data collection, its use is not subject to 21 CFR 50, 21 CFR 56, or 21 CFR 812. Data collection via EIT will occur when the subject is in a quiet, sleeping state, and can be accomplished in a convenient time period when care givers or parents are not interacting with the subject.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  1. All infants admitted to the NICU at SMBHWN
  2. Informed consent obtained
  3. Atelectasis confirmed on CXR
  4. Pneumothorax confirmed on CXR
Exclusion Criteria
  1. Declined consent
  2. Infants with known congenital anomalies

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Atelectasis or PneumothoraxDetecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT)Infants with asymmetric lung disease (i.e. atelectasis or pneumothorax) confirmed by chest radiograph
Primary Outcome Measures
NameTimeMethod
Pneumothorax: Change in measured % Unventilated Lung between TimePeriods (t1 and t2)Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery

To determine pneumothorax is the percentage of lung areas with non-negligible impedance change during breathing.

Atelectasis: Change in measured % Unventilated Lung between TimePeriods (t1 and t2)Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery

Atelectasis will be calculated using the percentage of the lung fields that are not engaged in tidal volume.(VT)

Secondary Outcome Measures
NameTimeMethod
Geometric Center of Ventilation (CoV)Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery

In the human lung the ideal non-dependent to dependent CoV is 63%. Thus a value of 55% would indicate greater ventilation in the non-dependent lung.

Change in % of total tidal volume (VT) within 8 lung regionsBaseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery

% of total tidal volume will be determined from the trough and peak-to-peak height of the time-volume EIT within the 8 regions of interest

Relative change in uncalibrated aeration (end-expiratory lung volume)Baseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery

End-expiratory lung volume will be analyzed using four ventral to dorsal regions of interest (ROI) by EIT

Regional distribution of tidal volumeBaseline, pre-intervention/procedure/surgery and Immediately after the intervention/procedure/surgery

Regional distribution of tidal volume will be analyzed using four ventral to dorsal regions of interest (ROI) by EIT

Trial Locations

Locations (1)

Sharp Mary Birch Hospital for Women & Newborns

🇺🇸

San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath